Cannabinoid treatment renders neurons less vulnerable than oligodendrocytes in experimental autoimmune encephalomyelitis

Medicin og biovidenskab

• Atrophy 18%
• Autoimmune Experimental Encephalomyelitis 100%
• Calpain 79%
• Cannabinoids 99%
• Caspases 21%
• Cell Death 16%
• Central Nervous System 15%
• Chemokine CCL5 27%
• Cytokines 13%
• Dasyproctidae 30%
• Demyelinating Diseases 67%
• Immunosuppressive Agents 17%
• Interleukin-10 19%
• Interleukin-2 18%
• Interleukin-6 16%
• Multiple Sclerosis 18%
• Neurons 52%
• Neuroprotection 22%
• Oligodendroglia 93%
• Recurrence 12%
• Regulatory T-Lymphocytes 21%
• Therapeutics 13%